Thomas Ramdahl, chairman
Thomas Ramdahl is an independent health industry consultant. Recently he was Managing Director of Bayer AS. Thomas joined Bayer as a result of Bayer’s acquisition of the pharmaceutical company Algeta ASA, where Thomas was the first CEO and one of the key persons building the company. Before this Thomas held several management positions in different divisions of Norsk Hydro/Pronova. He has also worked as a research scientist at the University of California, Riverside and at the Central Institute for Industrial Research, Oslo. He holds an MSc in organic chemistry from the Norwegian Institute of Technology and a PhD in environmental chemistry from the University of Oslo.
Børge Bogaard, vice chairman
M.Sc, Stanford University, MBA Norwegian School of Management. Hands-on manager with solid operational experience from two decades of P&L responsibilities overseeing and spearheading several new companies. Broad international commercial and leadership experience from 20 years in the US. Well-developed networks in the academic and business environments. Acted as board member and advisor for several Norwegian and US companies. Experience from turnarounds and accelerate growth start-ups, as well as corporate environments.
Mobile US: +1 617 416 7180
Mobile Norway: +47 918 26 075
Anita Tunold has more than 13 years of experience in government affairs, communications and marketing within the health industry. She is currently Director for Communications and External Affairs in in Norway’s leading private health care provider Aleris Helse and before that she held management positions in GSK Pharma. She has also worked as a senior advisor in the Norwegian Ministry of Education & Research and the Ministry of Trade & Industry, as well as the European Commission. Anita holds a Master of Arts in Political Science from the College of Europe in Bruges, Institut d’Etudes Politiques in Paris and the University of Oslo.
Åge Nærdal has a M.Sc.Pharmacy degree from the University of Oslo
and more than 30 years of experience from sales, marketing and
leadership positions in pharmaceutical industry. He was Managing
Director in GSK Norway for 13 years until 2015 and Board Member in
Legemiddelindustrien (Pharma trade association) for 10 years during
this time. In 2015, he founded his own consultancy (Pharmamentor AS)
and is associated partner in First House AS.